Physiologically based modeling of n-hexane kinetics in humans following inhalation exposure at rest and under physical exertion: Impact on free 2,5-hexanedione in urine and on n-hexane in alveolar air

Journal of Occupational and Environmental Hygiene

Volumn 2, Issue 2, 2005, Pages 86-97

  Hamelin, G ^a   Charest Tardif, G ^a   Truchon, G ^b   Tardif, R ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUT DE RECHERCHE ROBERT SAUVÉ EN SANTÉ ET EN SÉCURITÉ DU TRAVAIL   (Canada)

Author keywords

2,5 hexanedione; Alveolar air concentration; Biological monitoring; n hexane; Toxicokinetic modeling

Indexed keywords

ACETONYLACETONE; HEXANE;

ARTICLE; BIOLOGICAL MONITORING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INHALATION; MONTE CARLO METHOD; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; TOXICOKINETICS; URINARY EXCRETION; URINE LEVEL; WORKLOAD;

EXERCISE; FORECASTING; HEXANES; HEXANONES; HUMANS; INHALATION EXPOSURE; KINETICS; MODELS, BIOLOGICAL; NEUROTOXINS; OCCUPATIONAL EXPOSURE; PULMONARY ALVEOLI; RESPIRATION; WORKLOAD;

EID: 13444280192     PISSN: 15459624     EISSN: None     Source Type: Journal    
DOI: 10.1080/15459620590909673     Document Type: Article

References (42)

1. Graham, D.G., V. Amarnath, W.M. Valentine, S.J. Pyle, and D.C. Anthony: Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 25:91-112 (1995).
2. Fedtke, N., and H.M. Bolt: The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man. Arch. Toxicol. 612:131-137 (1987).
3. Manini, P., R. Andreoli, A. Mutti, E. Bergamaschi, and I. Franchini: Determination of free and glucuronated hexane metabolites without prior hydrolysis by liquid- and gas-chromatography coupled with mass spectrometry. Toxicol. Lett. 108:225-231 (1999).
4. American Conference of Governmental Industrial Hygienists (ACGIH®): 2001 TLVs® and BEIs® for Chemical Substances and Physical Agents. Cincinnati, Ohio: AGCIH, 2001.
5. Hamelin, G., G. Truchon, and R. Tardif: Comparison of unchanged n-hexane in alveolar air and 2,5-hexanedione in urine for the biological monitoring of n-hexane exposure in human volunteers. Int. Arch. Occup. Environ. Health 77:264-270 (2004).
6. Thomas, R.S., P.L. Bigelow, T.J. Keefe, and R.S. Yang: Variability in biological exposure indices using physiologically based pharmacokinetic modeling and MonteCarlo simulation. Am. Ind. Hyg. Assoc. J. 571:23-32 (1996).
7. Perbellini, L., P. Mozzo, F. Brugnone, and A. Zedde: Physiologicomathematical model for studying human exposure to organic solvents: Kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br. J. Ind. Med. 4311:760-768 (1986).
8. Perbellini, L., P. Mozzo, D. Olivato, and F. Brugnone: "Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model. Am. Ind. Hyg. Assoc. J. 517:356-362 (1990).
9. Yu, X., G. Johanson, G. Ichihara, et al.: Physiologically based pharmacokinetic modeling of metabolic interactions between n-hexane and toluene in humans. J. Occup. Health 40:293-301 (1998).
10. Ali, N., and R. Tardif: Toxicokinetic modeling of the combined exposure to toluene and n-hexane in rats and humans. J. Occup. Health 41:95-l03 (1999).
11. Lof, A., and G. Johanson: Toxicokinetics of organic solvents: A review of modifying factors. Crit. Rev. Toxicol. 28:511-650 (1998).
12. Astrand, I.: Uptake of solvents in the blood and tissues of man. A review. Scand. J. Work, Environ. Health 1:199-218 (1975).
13. Csanady, G.A., and J.G. Filser: The relevance of physical activity for the kinetics of inhaled gaseous substances. Arch. Toxicol. 74:663-672 (2001).
14. Heinrich-Ramm, R., M. Jakubowski, B. Heinzow, J.M. Christensen, E. Olsen, and O. Hertel: Biological monitoring for exposure to volatile organic compounds (VOCs). Pure Appl. Chem. 72:385-436 (2000).
15. Droz, P.O.: Pharmacokinetic modeling as a tool for biological monitoring. Int. Arch. Occup. Environ. Health 65:S53-S59 (1993).
16. Veulemans, H., E. Van Vlem, H. Janssens, R. Masschelein, and A. Leplat: Experimental human exposure to n-hexane. Study of the respiratory uptake and elimination, and of n-hexane concentrations in peripheral venous blood. Int. Arch. Occup. Environ. Health 49:251-263 (1982).
17. Kawai, T., K. Mizunuma, T. Yasugi, Y. Uchida, and M. Ikeda: The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane. Int. Arch. Occup. Environ. Health 62:403-408 (1990).
18. Tardif, R., G. Charest-Tardif, J. Brodeur, and K. Krishnan: Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 1441:120-134 (1997).
19. Gargas, M.L., R.J. Burgess, D.J. Voisard, G.H. Cason, and M.E. Andersen: Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99 (1989).
20. Fisher, J., D. Mahle, I. Bankston, R. Greene, and J. Gearhart: Lactational transfer of volatile chemicals in breast milk. Am. Ind. Hyg. Assoc. J. 55:425-431 (1997).
21. Evans, M.V., and M.E. Andersen: Sensitivity analysis and the design of gas uptake inhalation studies. Inhalation Toxicol. 7:1075-1094 (1995).
22. Tardif, R., P.O. Droz, G. Charest-Tardif, G. Pierrehumbert, and G. Truchon: Impact of human variability on the biological monitoring of exposure to toluene: I. Physiologically based toxicokinetic modelling. Toxicol. Lett. 134:155-163 (2002).
23. Pierrehumbert, G., P.O. Droz, R. Tardif, G. Charest-Tardif, and G. Truchon: Impact of human variability on the biological monitoring of exposure to toluene, phenol, lead, and mercury: II. Compartmental based toxicokinetic modelling. Toxicol. Lett. 134:165-175 (2002).
24. Shibata, E., G. Johanson, A. Lof, L. Ernstgard, E. Gullstrand, and K. Sigvardsson: Changes in n-hexane toxicokinetics in short-term single exposure due to co-exposure to methyl ethyl ketone in volunteers. Int. Arch. Occup. Environ. Health 75:399-405 (2002).
25. Brugnone, F., L. Perbellini, L. Grigolini, and P. Apostoli: Solvent exposure in a shoe upper factory. Int. Arch. Occup. Environ. Health 42:51-62 (1978).
26. Van Engelen, J.G.M., W.R. Haan, J.J.G. Opdam, and G.J. Mulder: Effect of coexposure to methyl ethyl ketone (MEK) on n-hexane toxicokinetics in human volunteers. Toxicol. Appl. Pharmacol. 144:385-395 (1997).
27. Mutti, A., M. Falzoi, S. Lucertini, et al.: n-Hexane metabolism in occupationally exposed workers. Br. J. Ind. Med. 47:533-538 (1984).
28. Periago, J.F., A. Cardona, D. Marhuenda, et al.: Biological monitoring of occupational exposure to n-hexane by exhaled air analysis and urinalysis. Int. Arch. Occup. Environ. Health 65:275-278 (1993).
29. Perbellini, L., F. Brugnone, D. Caretta, and G. Maranelli: Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br. J. Ind. Med. 42:162-167 (1985).
30. Cardona, A., D. Marhuenda, M.J. Prieto, J. Marti, J.F. Periago, and J.M. Sanchez: Behaviour of urinary 2,5-hexanedione in occupational co-exposure to n-hexane and acetone. Int. Arch. Occup. Environ. Health 68:88-93 (1996).
31. Kawai, T., T. Yasugi, K. Mizunuma, et al.: Dose-dependent increase in 2.5-hexanedione in the urine of workers exposed to n-hexane. Int. Arch. Occup. Environ. Health 65:285-291 (1991).
32. Kawai, T., T. Yasugi, K. Mizunuma, S. Horiguchi, and M. Ikeda: Urinalysis vs. blood analysis, as a tool for biological monitoring of solvent exposure. Toxicol. Lett. 65:333-343 (1992a).
33. Kawai, T., T. Yasugi, K. Mizunuma, et al.: Comparative evaluation of urinalysis and blood analysis as means of detecting exposure to organic solvents at low concentrations. Int. Arch. Occup. Environ. Health 64:223-234 (1992b).
34. Kawai, T., Y. Miyama, S. Horiguchi, et al.: Possible metabolic interaction between hexane and other solvents co-exposed at sub-occupational exposure limit levels. Int. Arch. Occup. Environ. Health 75:449-456 (2000).
35. Iwata, M., Y. Takeuchi, N. Hisanaga, and Y. Ono: Changes of n-hexane neurotoxicity and its urinary metabolites by long-term co-exposure with MEK or toluene. Int. Arch. Occup. Environ. Health 54:273-281 (1984).
36. Shibata, E., J. Huang, Y. Ono, et al.: Changes in urinary n-hexane metabolites by co-exposure to various concentrations of methyl ethyl ketone and fixed n-hexane levels. Arch. Toxicol. 64:165-168 (1990).
37. Ichihara, G., I. Saito, M. Kamijima, et al.: Urinary 2.5-hexanedione increases with potentiation of neurotoxicity in chronic coexposure to n-hexane and methyl ethyl ketone. Int. Arch. Occup. Environ. Health 71:100-104 (1998).
38. Mayan, O., J.P. Teixeira, and A.F. Pires: Biological monitoring of n-hexane exposure in Portuguese shoe manufacturing workers. Appl. Occup. Environ. Hyg. 16:736-741 (2001).
39. Bolt, H.M., P.H. Roos, and R. Their: The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: Consequences for occupational and environmental medicine. Int. Arch. Occup. Environ. Health 76:174-185 (2003).
40. Iba, M.M., J. Fung, and F.J. Gonzalez: Functional Cyp2e1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse. Arch. Toxicol. 74:582-586 (2000).
41. Portier, C.J., and N.L. Kaplan: Variability of safe dose estimates when using complicated models of the carcinogenic process: A case-study: Methylene chloride. Fundam. Appl. Toxicol. 13:533-544 (1989).
42. Laparé, S., R. Tardif, and J. Brodeur: Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air II. 1,1,1-trichloroethaneand trichloroethylene. Int. Arch. Occup. Environ. Health 67:375-394 (1995).